These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 19621336)

  • 1. c-Rel is a transcriptional repressor of EPHB2 in colorectal cancer.
    Fu T; Li P; Wang H; He Y; Luo D; Zhang A; Tong W; Zhang L; Liu B; Hu C
    J Pathol; 2009 Sep; 219(1):103-13. PubMed ID: 19621336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of inactivation of the receptor tyrosine kinase EPHB2 in colorectal tumors.
    Alazzouzi H; Davalos V; Kokko A; Domingo E; Woerner SM; Wilson AJ; Konrad L; Laiho P; Espín E; Armengol M; Imai K; Yamamoto H; Mariadason JM; Gebert JF; Aaltonen LA; Schwartz S; Arango D
    Cancer Res; 2005 Nov; 65(22):10170-3. PubMed ID: 16288001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced expression of EphB2 that parallels invasion and metastasis in colorectal tumours.
    Guo DL; Zhang J; Yuen ST; Tsui WY; Chan AS; Ho C; Ji J; Leung SY; Chen X
    Carcinogenesis; 2006 Mar; 27(3):454-64. PubMed ID: 16272170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EphB2 is a prognostic factor in colorectal cancer.
    Jubb AM; Zhong F; Bheddah S; Grabsch HI; Frantz GD; Mueller W; Kavi V; Quirke P; Polakis P; Koeppen H
    Clin Cancer Res; 2005 Jul; 11(14):5181-7. PubMed ID: 16033834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EPHB2 germline variants in patients with colorectal cancer or hyperplastic polyposis.
    Kokko A; Laiho P; Lehtonen R; Korja S; Carvajal-Carmona LG; Järvinen H; Mecklin JP; Eng C; Schleutker J; Tomlinson IP; Vahteristo P; Aaltonen LA
    BMC Cancer; 2006 Jun; 6():145. PubMed ID: 16740153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preferential induction of EphB4 over EphB2 and its implication in colorectal cancer progression.
    Kumar SR; Scehnet JS; Ley EJ; Singh J; Krasnoperov V; Liu R; Manchanda PK; Ladner RD; Hawes D; Weaver FA; Beart RW; Singh G; Nguyen C; Kahn M; Gill PS
    Cancer Res; 2009 May; 69(9):3736-45. PubMed ID: 19366806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EphB2 expression across 138 human tumor types in a tissue microarray: high levels of expression in gastrointestinal cancers.
    Lugli A; Spichtin H; Maurer R; Mirlacher M; Kiefer J; Huusko P; Azorsa D; Terracciano L; Sauter G; Kallioniemi OP; Mousses S; Tornillo L
    Clin Cancer Res; 2005 Sep; 11(18):6450-8. PubMed ID: 16166419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of EphA4 gene and reduced expression of EphB2 gene correlates with liver metastasis in colorectal cancer.
    Oshima T; Akaike M; Yoshihara K; Shiozawa M; Yamamoto N; Sato T; Akihito N; Nagano Y; Fujii S; Kunisaki C; Wada N; Rino Y; Tanaka K; Masuda M; Imada T
    Int J Oncol; 2008 Sep; 33(3):573-7. PubMed ID: 18695888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic and epigenetic analysis of the EPHB2 gene in gastric cancers.
    Song JH; Kim CJ; Cho YG; Kwak HJ; Nam SW; Yoo NJ; Lee JY; Park WS
    APMIS; 2007 Feb; 115(2):164-8. PubMed ID: 17295683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclooxygenase-2 inhibitors down-regulate osteopontin and Nr4A2-new therapeutic targets for colorectal cancers.
    Zagani R; Hamzaoui N; Cacheux W; de Reyniès A; Terris B; Chaussade S; Romagnolo B; Perret C; Lamarque D
    Gastroenterology; 2009 Oct; 137(4):1358-66.e1-3. PubMed ID: 19549529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of A9 region mutation in EphB2 gene in the prognosis of patients with colorectal adenocarcinoma.
    Vidaurreta M; Rafael S; Veganzones S; de la Orden V; Fernández C; Gómez-Casaseca R; Cerdán J; Maestro M
    Ann Surg Oncol; 2011 May; 18(5):1501-5. PubMed ID: 21161727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.
    Melotte V; Lentjes MH; van den Bosch SM; Hellebrekers DM; de Hoon JP; Wouters KA; Daenen KL; Partouns-Hendriks IE; Stessels F; Louwagie J; Smits KM; Weijenberg MP; Sanduleanu S; Khalid-de Bakker CA; Oort FA; Meijer GA; Jonkers DM; Herman JG; de Bruïne AP; van Engeland M
    J Natl Cancer Inst; 2009 Jul; 101(13):916-27. PubMed ID: 19535783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EphB receptor activity suppresses colorectal cancer progression.
    Batlle E; Bacani J; Begthel H; Jonkheer S; Gregorieff A; van de Born M; Malats N; Sancho E; Boon E; Pawson T; Gallinger S; Pals S; Clevers H
    Nature; 2005 Jun; 435(7045):1126-30. PubMed ID: 15973414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A negative feedback regulatory loop associates the tyrosine kinase receptor ERBB2 and the transcription factor GATA4 in breast cancer cells.
    Hua G; Zhu B; Rosa F; Deblon N; Adélaïde J; Kahn-Perlès B; Birnbaum D; Imbert J
    Mol Cancer Res; 2009 Mar; 7(3):402-14. PubMed ID: 19276186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of promoter regulatory elements involved in downexpression of the DNA polymerase kappa in colorectal cancer.
    Lemée F; Bavoux C; Pillaire MJ; Bieth A; Machado CR; Pena SD; Guimbaud R; Selves J; Hoffmann JS; Cazaux C
    Oncogene; 2007 May; 26(23):3387-94. PubMed ID: 17099721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cupredoxin-cancer interrelationship: azurin binding with EphB2, interference in EphB2 tyrosine phosphorylation, and inhibition of cancer growth.
    Chaudhari A; Mahfouz M; Fialho AM; Yamada T; Granja AT; Zhu Y; Hashimoto W; Schlarb-Ridley B; Cho W; Das Gupta TK; Chakrabarty AM
    Biochemistry; 2007 Feb; 46(7):1799-810. PubMed ID: 17249693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions.
    Zou XP; Zhang B; Zhang XQ; Chen M; Cao J; Liu WJ
    Hum Pathol; 2009 Nov; 40(11):1534-42. PubMed ID: 19695681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and function of ephrin-B1 and its cognate receptor EphB2 in human atherosclerosis: from an aspect of chemotaxis.
    Sakamoto A; Ishibashi-Ueda H; Sugamoto Y; Higashikata T; Miyamoto S; Kawashiri MA; Yagi K; Konno T; Hayashi K; Fujino N; Ino H; Takeda Y; Yamagishi M
    Clin Sci (Lond); 2008 May; 114(10):643-50. PubMed ID: 18092944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High EPHB2 mutation rate in gastric but not endometrial tumors with microsatellite instability.
    Davalos V; Dopeso H; Velho S; Ferreira AM; Cirnes L; Díaz-Chico N; Bilbao C; Ramírez R; Rodríguez G; Falcón O; León L; Niessen RC; Keller G; Dallenbach-Hellweg G; Espín E; Armengol M; Plaja A; Perucho M; Imai K; Yamamoto H; Gebert JF; Díaz-Chico JC; Hofstra RM; Woerner SM; Seruca R; Schwartz S; Arango D
    Oncogene; 2007 Jan; 26(2):308-11. PubMed ID: 16819508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of Vitamin D receptor in the intestinal induction of human ABCB1.
    Tachibana S; Yoshinari K; Chikada T; Toriyabe T; Nagata K; Yamazoe Y
    Drug Metab Dispos; 2009 Aug; 37(8):1604-10. PubMed ID: 19460946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.